BRCAvantage™: An In-depth Discussion



About this Webinar

Date: Monday, July 21, 2014

Author: Waldman, Frederic, MD, PhD
Medical Director, Cancer Diagnostics
Quest Diagnostics Nichols Institute
San Juan Capistrano, CA
Also by this Author 

Category: Webinar


Quest Diagnostics’ Frederic Waldman, MD, and Wendy Conlon, CGC, will present an in-depth look at BRCA1 and BRCA2 testing, describe the role of the genetic counselor in the management of patients and explain the details of the Quest Diagnostics BRCAvantage™ tests and how to interpret results.

Program Objectives:

At the conclusion of this program, participants will be able to:

  • Recognize the clinical relevance of BRCA1 and BRCA2 testing including risks associated with mutations and risk reduction options

  • Understand the details of the Quest Diagnostics BRCAvantage™ tests including technical assay design, specific tests and annotation and reporting

  • Discuss other BRCA testing services including genetic counseling, preauthorization, and financial assistance services